While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
Not all companies are created equal, and StockStory is here to surface the ones with real upside. That said, here are two cash-producing companies that reinvest wisely to drive long-term success and one that may face some trouble.
One Stock to Sell:
Tilly's (TLYS)
Trailing 12-Month Free Cash Flow Margin: 1.9%
With an emphasis on skate and surf culture, Tilly’s (NYSE: TLYS) is a specialty retailer that sells clothing, footwear, and accessories geared towards fashion-forward teens and young adults.
Why Are We Out on TLYS?
- Reduction in its number of stores signals a focus on profitability through targeted consolidation
- Persistent operating margin losses suggest the business manages its expenses poorly
Tilly's is trading at $4.62 per share, or 34.1x forward P/E. If you’re considering TLYS for your portfolio, see our FREE research report to learn more.
Two Stocks to Watch:
AbbVie (ABBV)
Trailing 12-Month Free Cash Flow Margin: 28.3%
Born from a 2013 spinoff of Abbott Laboratories' pharmaceutical business, AbbVie (NYSE: ABBV) is a biopharmaceutical company that develops and markets medications for autoimmune diseases, cancer, neurological disorders, and other complex health conditions.
Why Could ABBV Be a Winner?
- Enormous revenue base of $64.39 billion gives it economies of scale and advantages over new entrants due to the industry’s regulatory complexity
- ABBV is a free cash flow machine with the flexibility to invest in growth initiatives or return capital to shareholders
- Industry-leading 18.6% return on capital demonstrates management’s skill in finding high-return investments
AbbVie’s stock price of $271.68 implies a valuation ratio of 17.9x forward P/E. Is now the time to initiate a position? See for yourself in our full research report, it’s free.
EQT (EQT)
Trailing 12-Month Free Cash Flow Margin: 43.4%
The largest natural gas producer in the United States by daily volume, EQT (NYSE: EQT) produces natural gas and natural gas liquids from wells drilled in the Appalachian Basin.
Why Will EQT Outperform?
- Annual revenue growth of 15.3% over the past ten years was outstanding, reflecting market share gains this cycle
- EBITDA profits increased over the last five years as the company gained some leverage on its fixed costs and became more efficient
- Strong free cash flow margin of 30.8% enables it to reinvest or return capital consistently
At $52.95 per share, EQT trades at 16.9x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.
